Patient‐reported outcomes in studies of diabetes technology: What matters
2024

Patient-Reported Outcomes in Diabetes Technology

publication Evidence: moderate

Author Information

Author(s): Liarakos Alexandros L., Crabtree Thomas S. J., Wilmot Emma G.

Primary Institution: University Hospitals of Derby and Burton NHS Foundation Trust, University of Nottingham

Hypothesis

The study investigates the impact of diabetes technologies on patient-reported outcome measures (PROMs) in individuals with type 1 and type 2 diabetes.

Conclusion

Diabetes technologies can improve patient-reported outcomes, particularly in type 1 diabetes, but more research is needed to assess their impact in type 2 diabetes.

Supporting Evidence

  • Diabetes technologies have revolutionized care for type 1 diabetes and show promise for type 2 diabetes.
  • Continuous glucose monitoring systems can improve patient-reported outcomes by managing hypoglycaemia.
  • Hybrid closed-loop therapies have been associated with increased treatment satisfaction and improved quality of life.

Takeaway

This study looks at how new diabetes technologies help people feel better about managing their diabetes, not just about their blood sugar levels.

Methodology

The study is a narrative review that summarizes findings from various trials assessing the impact of diabetes technologies on PROMs.

Potential Biases

The focus on glycaemic outcomes may overshadow the importance of PROMs in diabetes management.

Limitations

Most studies included PROMs as secondary outcomes, limiting the ability to draw strong conclusions about their effectiveness.

Participant Demographics

The review includes studies involving adults with type 1 and type 2 diabetes.

Digital Object Identifier (DOI)

10.1111/dom.15858

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication